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Abstract
Background: Atrial fibrillation (AF) is associated with high risk of stroke and other thromboembolic 
complications. The OCULUS study aimed to evaluate the effectiveness of the three-dimensional (3D) 
movie in teaching patients about the consequences of AF and pharmacological stroke prevention. 
Methods: The study was based on a questionnaire and included 100 consecutive patients (38% 
women, 62% with AF history). Using the oculus glasses and a smartphone, a 3D movie describing the 
risk of stroke in AF was shown. Similar questions were asked immediately after, 1 week and 1 year 
after the projection. 
Results: Before the projection 22/100 (22.0%) declared stroke a consequence of AF, while immediately 
after 83/100 (83.0%) (p < 0.0001) patients declared this consequence. Seven days after, stroke as AF 
consequence was chosen by 74/94 (78.7%) vs. 22/94 (23.4%) when compared to the baseline knowledge; 
p < 0.0001, a similar trend was also observed in  1-year follow-up (64/90 [71.1%] vs. 21/90 [23.3%]; 
p < 0.0001). Before the projection 88.3% (83/94) patients responded, that drugs may reduce the risk of 
stroke, and after 1 week the number of patients increased to (94/94 [100%]; p = 0.001). After 1 year 
87/90 (96.7%) answered that drugs may diminish the risk of stroke (p = 0.02 in comparison to the 
baseline survey 78/90 [86.7%]). Use of oral anticoagulation to reduce the risk of stroke was initially 
chosen by 66/94 (70.2%), by 90/94 (95.7%; p < 0.0001) 7 days after and by 83/90 (92.2%; p < 0.0001) 
1 year after. 
Conclusions: 3D movie is an effective tool in transferring knowledge about the consequences of AF and 
the pivotal role of oral anticoagulation in stroke prevention. (Cardiol J 2019; 26, 3: 260–264)
Trial registration: ClinicalTrials.gov, NCT03104231. Registered on 28 March 2017.
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Introduction
Atrial fibrillation (AF) is the most common 
cardiac arrhythmia in adults, with a significant risk 
of morbidity and mortality, mainly due to increased 
risk of stroke and systemic embolism. AF is inde-
pendently correlated with a 2-fold increased risk of 
all-cause mortality in women and a 1.5-fold in men [1]. 
The prevalence of AF is approximately 3% in adults 
aged 20 years or older and increases with age and 
presence of hypertension, heart failure, coronary 
artery disease, valvular heart disease, obesity, 
diabetes mellitus and chronic kidney disease [1].
Nowadays, identification and prevention of AF 
risk factors, as well as prevention of thromboem-
bolic events constitute the fundamentals of com-
prehensive care in AF [1]. Most thromboembolic 
events may be prevented by oral anticoagulation 
(OAC), which is suggested to be prescribed to the 
majority of patients with AF basing on CHA2DS2-
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-VASc score [1]. The current guidelines for the 
management of AF patients highlight the important 
role of education in treatment [1, 2]. Therefore, 
one of the most important factors leading to the 
achievement of clinical benefit from OAC therapy is 
an effective cooperation of patients with physicians. 
Thus, physicians should introduce novel e-solu-
tions to the communication process with patients 
to increase compliance [3]. Three-dimensional (3D) 
and virtual reality (VR) models are helpful in every 
day medical practice [4, 5] but could be also used 
as educational tools.
The OCULUS study aimed to evaluate wheth-
er the VR-3D movie-based education is effective 
in improving patient knowledge about the conse-
quences of AF and pharmacological possibilities in 
reducing the risk of stroke. An additional objective 
of the analysis was to assess factors contributing 
to OAC usage in the prevention of stroke.
Methods
Study design and population
The OCULUS was a prospective, single center 
study. The study included hospitalized patients, 
who were over 18 years old. Only patients with 
previously diagnosed dementia were excluded from 
the study. The recruitment phase of the OCULUS 
study lasted from April 2016 to August 2016. Local 
ethics committees approved the study. All patients 
were provided with detailed information and signed 
informed written consent. 
The study was based on a questionnaire 
(Suppl. material), designed by the authors of the 
study. The questionnaire was composed of ques-
tions about sex, age, education, current job, AF 
history, as well as knowledge about consequences 
of AF and the importance of OAC therapy in 
stroke prevention. Consequently, the brief VR-3D 
movie which is available on Google Play and 
Appstore was shown using oculus glasses and 
a smartphone (a version prepared for men is avail-
able at the address: https://www.youtube.com/
watch?v=5WFxq_m88ds, whereas a version for 
women is available at the address: https://www.
youtube.com/watch?v=S8i7LxBBv0g). The Pfizer 
Company allowed the authors of the study to use 
the movie. The movie’s plot to inform patients 
about the risk of stroke and possibilities of its pre-
vention by using OAC. Subsequently, patients were 
asked a few questions, including what the movie 
was about, whether AF can affect a patient’s life in 
a negative way, whether it is possible to reduce the 
risk of stroke and if or by what types of drugs also 
reduce the risk of stroke. Similar questions were 
asked to the patients immediately after the movie, 
1 week and 1 year later (via telephone follow-up).
Statistical analysis
Categorical variables are presented as a per-
centage of total for the group. Comparisons  of re-
sults before and after watching the movie was made 
using the McNemar test. Bonferroni correction was 
used for multiple comparisons. Logistic regres-
sion was performed to assess factors contributing 
to OAC usage as a prevention of stroke. A value of 
p < 0.05 was considered significant. The calcula-
tions were performed using SAS software 9.4.
Results 
The current analysis included 100 patients 
(38% women). Mean age of the study group was 
63 ± 15 years. Data on 7-day follow-up were available 
for 94 patients (6 patients were lost to telephone 
follow-up), whereas the 1-year follow-up data 
were collected from 90 patients (10 patients had 
not completed the telephone follow-up). Previous 
history of AF was reported in 62/100 (62.0%) of the 
patients examined. Before projection of the movie 
22/100 (22.0%) of patients answered that stroke is 
a dangerous consequence of AF, while immediately 
after the projection the number of patients sig-
nificantly increased (83/100 [83.0%]; p < 0.0001). 
One week after the number of patients choosing 
stroke as a consequence of AF was still significantly 
higher in comparison to the knowledge before 
the projection (74/94 [78.7%] vs. 22/94 [23.4%]; 
p < 0.0001), similar trend was observed also in the 
1-year follow-up (64/90 [71.1%] vs. 21/90 [23.3%]; 
p < 0.0001) (Fig. 1). High number of patients 
(83/94; 88.3%) asked prior to the projection and 
all patients (94/94; 100%) who were asked after 
7 days responded that the risk of stroke may be re-
duced by using a specific pharmacological therapy 
(p = 0.001). Moreover, in 1-year follow-up 87/90 
(96.67%) of patients confirmed that specific drugs 
may serve as a possibility to diminish stroke risk 
(p = 0.023 in comparison to the survey before the 
projection 78/90 [(86.7%]). As for drugs reducing 
the risk of stroke, OAC  chosen by 66/94 (70.2%) 
of patients prior to the projection and by 90/94 
(95.7%) of patients a week after watching the 
movie (p < 0.0001). Importantly, 1 year following 
the projection the knowledge of OAC as a phar-
macologic possibility of stroke risk reduction was 
significantly improved in comparison to the knowl-
edge prior watching the movie (83/90 [92.2%] vs. 
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60/90 [66.7%]; p < 0.0001) (Fig. 2). Before the 
projection 54/94 (57.5%) of patients confirmed 
previous treatment with OAC, whereas 7 days after 
the projection the usage of OAC was declared by 
66/94 (70.2%) of the patients asked (p = 0.004). 
Also, 1 year after the projection significantly higher 
number of patients confirmed use of OAC therapy 
when compared to the baseline survey (65/90 
[72.2%] vs. 50/90 [55.6%]; p = 0.006) (Fig. 3). The 
VR-3D movie was acknowledged as a useful tool to 
spread awareness of consequences of AF by 99/100 
(99.0%) of the study participants. Approximately 
all of the patients (99/100; 99.0%) confirmed that 
they would enjoy watching similar movies about 
other diseases. One week after watching the 
movie 91/93 (97.9%) of patients declared using 
prescribed OAC therapy in the future, due to the 
gained knowledge through watching the movie 
about the consequences associated with AF. The 
univariate analysis did not reveal any statistically 
significant relations between age or gender, and 
the frequency of marking stroke as a consequence 
of AF or choosing OAC as a possibility of reducing 
the risk of stroke. 
Discussion
The results obtained clearly show that knowl-
edge about the consequences of AF results in an 
improved declared adherence to treatment with 
OAC. The vast majority of patients acknowledged 
that the VR-3D movie technology is an interesting 
and useful tool to spread the awareness about AF, 
as well as other diseases. 
Results from the European Heart Rhythm 
Association (EHRA) Survey conducted in 53 
Figure 1. Percentages of patients declaring stroke 
a dangerous consequence of atrial fibrillation; A. Im-
mediately after the projection; B. One week after the 
projection; C. One year after the projection.
Figure 2. Percentages of patients choosing oral anti-
coagulants as drugs which reduce the risk of stroke; 
A. One week after projection; B. One year after projection.
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European centres revealed, that stroke and bleed-
ing risk management had the highest priority in 
discussion with AF patients in majority of centres 
(80.2%) [6]. However, none of the centres used 
the mobile phone applications to explain the risk 
of stroke, as a consequence of AF. The majority of 
centres (92.3%) included in this survey provided 
discussion with patients to describe the risk of 
stroke in AF. In addition to the conversation, some 
of the centres provided illustrative materials from 
pharmaceutical companies (23.1%), other printed 
materials (17.3%), links to websites (17.3%), 
specialized nurse (11.5%) or health psychologist 
(1 center). Moreover, there was estimated that 
the percentages of patients who would desist OAC 
despite the knowledge of advantages and risks of 
the therapy were: 0.0% in 13.7% of the centers, 
≤ 10% in 58.8%, 11–20% in 21.6% and 21–30% in 
5.9% of the centers. Interestingly, the prevailing 
reasons for OAC withdrawal were patient fear of 
bleeding (41.2% of the centers), underestimation 
of stroke risk despite having the proper knowledge 
(21.6%), deficient patient information about the 
risk of stroke (15.7%), unknown or other reasons 
(21.6%) [6]. Another EHRA Survey evaluating the 
level of education about the OAC, conducted in 
8 European centres reported, that 90% of patients 
with AF give the proper explanation for the OAC 
therapy (which was said as “to thin the blood”) [7]. 
It is known that management of OAC is chal-
lenging because of the need for an appropriate 
balance between hemorrhagic and thromboembolic 
risks, as well as due to different phenotypes of 
patients using this therapy. Interestingly, results 
from the EHRA Survey show that patients without 
schooling had the highest percentage of bleeding 
on OAC and previous strokes and the lowest use of 
OAC for stroke prevention [2]. The OCULUS study 
did not show any statistically significant correla-
tions between age or gender, and the frequency of 
marking stroke as a consequence of AF or choosing 
OAC as a possibility in reducing the risk of stroke. 
In 2014 Cleeren et al. [8] conducted a rand-
omized controlled trial which evaluated gaining and 
recall of knowledge on periodontitis by patients 
suffering from periodontitis. The authors revealed, 
that patients who were shown 3D animations had 
significantly higher scores in knowledge imme-
diately after the projection and in the following 
2 weeks in comparison to a narration and drawing 
group. Therefore, authors of the study agreed, that 
3D animations may be a useful tool in the education 
of patients. VR is also suggested to be effective as 
a diagnostic application in detecting mild cogni-
tive impairment [9]. Moreover, VR is concerned 
to be a useful additional tool in rehabilitation after 
ischemic stroke and cerebral palsy [10, 11]. It has 
been proven, that patients using VR applications 
experience less pain and distress, furthermore 
they also declare awillingness to use VR during 
the medical procedures related with pain [12]. Also 
other educational tools, such as an iPad-based ap-
plication (iBook), is suggested to be beneficial in 
otologic diseases in improving patient knowledge 
and satisfaction [13].
Limitations of the study
Some important limitations of the OCULUS 
study have to be acknowledged. First of all, the 
analyzed group of patients is relatively small. Sec-
ondly, a longer follow-up is required to assess the 
effectiveness of the 3D movie on patient knowledge 
and attitude towards compliance. Moreover, the 
OCULUS study enrolled only hospitalized patients. 
However, it could be hypothesized that, those pa-
tients may have a higher level of knowledge about 
AF and anticoagulation treatment and what may 
have had a significant influence on the obtained 
Figure 3. Percentages of patients who declare taking 
oral anticoagulants previously; A. One week after pro-
jection; B. One year after projection.
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results. Thus, there is a need to conduct such 
a study in the general population.
Conclusions
The OCULUS study shows, that a 3D movie 
is an effective tool in teaching patients about the 
consequences of AF and the important role of OAC 
in stroke prevention. Due to the interesting results 
of the current study, there is a need to create edu-
cational VR-3D movies, which may contribute to 
the improvement in patient compliance and better 
treatment outcomes for other diseases. Further 
multicentre studies would be helpful to evaluate 
the role of  VR-3D-movie-based knowledge trans-
fer for several diseases, not only in AF. 
Trial registration
The study has been registered in the Clini-
calTrials.gov, NCT03104231. Registered on 28 
March 2017.
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